CLINICAL_TRIALS
trial_result
· 2022-10-18
Clinical Trial Update: The POWERED Study: Prophylaxis With Metformin to Prevent PTDM [Phase 2]
Summary
Phase 2 trial update on using metformin prophylaxis to prevent post-transplant diabetes mellitus after kidney transplantation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Barts & The London NHS Trust | Conditions: Post-transplant Diabetes Mellitus, New Onset Diabetes After Transplant | Phase 2 | Status: COMPLETED